DLEU2-TRIM13在ERS条件下通过内质网自噬调控COPD肺泡上皮细胞损伤的作用机制研究
批准号:
82060014
项目类别:
地区科学基金项目
资助金额:
34.0 万元
负责人:
张剑青
依托单位:
学科分类:
慢性阻塞性肺疾病
结题年份:
2024
批准年份:
2020
项目状态:
已结题
项目参与者:
张剑青
中文摘要
COPD作为四大慢病之一成为重要的公共卫生问题,云南地区的COPD负担尤为严重。我们首次发现LncRNA Dleu2及TRIM13在COPD患者的肺泡上皮细胞中表达下调,并且在CSE诱导的AECII的ERS模型中TRIM13表达亦下调。据此,本项目拟构建ERS条件下AECII细胞自噬模型,研究过表达/干扰TRIM13对AECII细胞自噬负调控PI3K-Akt-mTOR信号通路、自噬正调控AMPK-mTOR信号通路的影响;观察过表达/干扰TRIM13前后细胞内自噬体、自噬溶酶体等超微结构以及TRIM13亚细胞分布的变化,进一步探寻TRIM13对内质网自噬的影响;观察过表达/干扰LncRNA Dleu2后对TRIM13及其下游信号通路的影响,从而最终阐明DLEU2-TRIM13在ERS下通过内质网自噬调控COPD肺泡上皮细胞损伤的作用及分子生物学机制,为COPD的诊断与治疗提供新证据。
英文摘要
As one of the four major chronic diseases, COPD has been a critical public health problem, and the burden from COPD in Yunnan region is particularly serious. We found for the first time that the expression of LncRNA Dleu2 and TRIM13 is down-regulated in alveolar epithelial cells of COPD patients, and the expression of TRIM13 is also down-regulated in the Endoplasmic Reticulum Stress (ERS) model of type II alveolar epithelial cells (AECII) induced by CSE. Accordingly, we plan to construct an AEC II cell autophagy model under ERS conditions, to study the effects of overexpression / interference of TRIM13 on the PI3K-Akt-mTOR signaling pathway which negatively regulate autophagy and AMPK-mTOR signaling pathway which positively regulate autophagy in the AEC II cells; to observe the changes of intracellular autophagosomes, autophagolysosomes and other ultrastructures and TRIM13 sub-cellular distribution before and after overexpression / interference with TRIM13, and to further explore the effect of TRIM13 on endoplasmic reticulum autophagy; and to observe the effect of overexpressing / interfering with LncRNA Dleu2 on TRIM13 and its downstream signaling pathways, so as to finally reveal and clarify the role and molecular biology mechanism of DLEU2-TRIM13 in regulating the injury of COPD alveolar epithelial cells through endoplasmic reticulum autophagy under ERS conditions, and thus it will provide new evidence for the diagnosis and treatment of COPD.
COPD作为四大慢病之一成为重要的公共卫生问题,云南地区的COPD负担尤为严重。我们首次发现LncRNA Dleu2及TRIM13在COPD患者的肺泡上皮细胞中表达下调,并且在CSE诱导的AECII的ERS模型中TRIM13表达亦下调。据此,本项目旨在探寻阐明DLEU2-TRIM13在ERS下通过内质网自噬调控COPD肺泡上皮细胞损伤的作用及分子生物学机制,为COPD的诊断与治疗提供新证据。. 我们构建A549细胞内质网应激诱导的内质网自噬模型。结果发现COPD患者和肺气肿大鼠肺组织中TRIM13的表达显著降低,且肺气肿大鼠肺组织中细胞凋亡水平显著升高。过表达TRIM13降低COPD模型中ERS相关分子的表达水平(GRP78、GRP94、XBP-1及eIF2a);降低ER-phagy水平(电镜下自噬溶酶体数量减少,内质网结构改善;LC3 II/LC3I、Beclin1的表达水平降低,自噬抑制分子BCL-2表达水平升高);敲低TRIM13却得到了完全相反的结果。而且,过表达TRIM13激活PI3K/Akt/mTOR信号通路。我们的研究结果显示,过表达LncRNA Dleu2 时,TRIM13蛋白表达上调,干扰LncRNA Dleu2,TRIM13表达下调,这表明LncRNA Dleu2对TRIM13具有正向调控关系。过表达TRIM13时,促凋亡蛋白(BMF、p53、cleaved-caspase-3、cleaved-caspase-7、Bax)的表达减少,同时促进抗凋亡蛋白Bcl-2的表达而发挥凋亡抑制作用,LC3II/ I表达下调,细胞自噬减少。然而干扰TRIM13 的表达则呈现出实验相反的结果。上述研究结果证实LncRNA Dleu2正向调控TRIM13,过表达LncRNA Dleu2时,TRIM13表达下调,细胞自噬与凋亡减轻从而起到保护A549细胞的作用。. TRIM13通过抑制ERS诱导的ER-phagy减轻了COPD的肺泡上皮细胞损伤,其机制可能是激活PI3K/AKT/mTOR信号通路。LncRNA Dleu2在慢阻肺患者肺组织中表达下调,可与TRIM13互作,介导慢阻肺肺泡上皮细胞的凋亡。Dleu2过表达可降低TRIM13所介导的慢阻肺肺泡上皮细胞的凋亡。
lncR-RP11-521C20.3-BMF信号通路在COPD肺泡上皮细胞凋亡中的作用机制研究
-
批准号:81860013
-
项目类别:地区科学基金项目
-
资助金额:35.0万元
-
批准年份:2018
-
负责人:张剑青
-
依托单位:
国内基金
海外基金